A detailed history of Advisors Asset Management, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 12,698 shares of RPRX stock, worth $320,370. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,698
Holding current value
$320,370
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$25.63 - $29.27 $325,449 - $371,670
12,698 New
12,698 $359,000
Q2 2021

Jul 30, 2021

SELL
$39.85 - $46.63 $75,874 - $88,783
-1,904 Closed
0 $0
Q1 2021

May 07, 2021

SELL
$42.34 - $52.82 $39,968 - $49,862
-944 Reduced 33.15%
1,904 $83,000
Q4 2020

Feb 12, 2021

BUY
$36.12 - $50.05 $102,869 - $142,542
2,848 New
2,848 $143,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.